ZimVie Corp (ZIMV): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand ZimVie Dental (ZIMV)

Logistics disruptions stemming from global conflicts are hindering product deliveries for ZimVie Inc., which is reflected in the company's smoothed P/S ratio, currently valued at 1.20. Stable demand for implants ensures the business's macro-resilience. Meanwhile, a strong dental brand helps maintain margins despite pricing pressure in the spine surgery segment.

Price-to-Revenue Ratio: ZimVie (ZIMV) for 04/28/2023 - 11/01/2025

Metric breakdowns and analytics for ZimVie Dental (ZIMV)

- stock quotes and analyst forecast:
Summary company analytics:zimvie.com
Mass-produced product of zimvie.com

Professional asset selection is based on identifying companies capable of maintaining market value amidst rising operating expenses. The market capitalization to annual revenue ratio, reflected in the P/S chart, measures the premium for future revenue growth, which for ZimVie Inc. (ZIMV) is supported by the stability of surgical component supply chains due to certified outsourcing and the absence of critical dependence on individual vendors.

Competitors of ZimVie Inc.

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAA (STAAR Surgical Corp) - Market Cap to Revenue|Price-to-Sales Ratio NAGE (Niagen)|ANGO (AngioDynamics, Inc.) - P/S Multiple|cerus.com (CERS) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Teknova (TKNO)|Market Cap to Revenue Monogram Technologies Inc. MGRM|Sharps Technology - Market Cap to Revenue|InfuSystem - Price-to-Revenue Ratio|Utah Medical Products - P/S Multiple|Price-to-Revenue Coefficient KORU Medical Systems KRMD|NYXH: P/S Multiple|Price to Sales Microbot Medical, Inc. (MBOT)|Market Cap to Revenue PDEX|ZTEK: Market Capitalization-to-Revenue Ratio|P/S Multiple ELUT|Price-to-Revenue Coefficient milestonescientific.com|Price-to-Revenue Ratio NEXGEL NXGL|RVP: Market Cap to Revenue Ratio|Harvard Bioscience - P/S Multiple|Femasys Corporation (FEMY) - Market Cap to Revenue|MHUA (meihuamed.com) - Market Cap to Revenue|POAI - Price-to-Revenue Coefficient|Market Cap to Revenue CJMB|Atrion Corp. - Price-to-Sales Ratio|P/S Multiple NURO